首页 | 本学科首页   官方微博 | 高级检索  
检索        

基于血浊理论探讨动脉粥样硬化前期病变的中医辨证施治
引用本文:孙莹心,韩萍,王新陆.基于血浊理论探讨动脉粥样硬化前期病变的中医辨证施治[J].天津中医药,2021,38(12):1544-1547.
作者姓名:孙莹心  韩萍  王新陆
作者单位:山东中医药大学中医学院, 济南 250355;青岛市中医医院, 青岛 266033;山东中医药大学, 济南 250355
基金项目:王新陆全国名中医传承工作室(鲁财社指[2018]52号);2021年山东省中医药高层次人才培育项目专项经费资助(鲁卫中医药科教字[2021]6号);山东省医药卫生科技发展计划项目(2016WS0305);青岛市医药科技发展计划项目(2020-WJZD044)。
摘    要:动脉粥样硬化是心脑血管疾病的独立危险因素,动脉硬化前期病变是动脉粥样硬化的亚临床阶段,在血浊理论的指导下干预治疗动脉粥样硬化前期病变,可降低急性心脑血管事件的发生率,也是中医治未病思想的体现,对于疾病的一级预防具有重大意义。

关 键 词:血浊理论  动脉粥样硬化前期  治未病  清化血浊
收稿时间:2021/8/16 0:00:00

Research on syndrome differentiation and treatment of preclinical atherosclerosis of traditional Chinese medicine based on blood turbidity theory
SUN Yingxin,HAN Ping,WANG Xinlu.Research on syndrome differentiation and treatment of preclinical atherosclerosis of traditional Chinese medicine based on blood turbidity theory[J].Tianjin Journal of Traditional Chin Medicine,2021,38(12):1544-1547.
Authors:SUN Yingxin  HAN Ping  WANG Xinlu
Institution:College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan 250355, China;Qingdao Hospital of Traditional Chinese Medicine, Qingdao 266033, China
Abstract:Atherosclerosis is an independent hazard factor for cardiovascular and cerebrovascular diseases. Preclinical atherosclerosis is the sub-clinical stage of atherosclerosis. Under the guidance of blood turbidity theory, treating the preclinical atherosclerosis can reduce the incidence of acute cardiovascular and cerebrovascular events. It is also the embodiment of the idea of prevention of diseases in traditional Chinese medicine, which is of great significance for the primary prevention of diseases.
Keywords:blood turbidity theory  preclinical atherosclerosis  prevention of disease  clearing blood turbidity
点击此处可从《天津中医药》浏览原始摘要信息
点击此处可从《天津中医药》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号